AVANOS 30788Recalls & reported problems
Avanos Medical, Inc. · ON-Q* Catheters-Soaker* · Class 2
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00193494307882), received between Aug 4, 2022 and Aug 4, 2022 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Material Integrity Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Material Integrity Problem2
Patient problems
- Foreign Body In Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 4, 2022Material Integrity Problem; Material Integrity Problem
AVANOS MEDICAL INC. RECEIVED A SINGLE REPORT THAT REFERENCED TWO DIFFERENT INCIDENCES, WHICH WERE ASSOCIATED WITH SEPARATE UNITS, INVOLVING TWO DIFFERENT PATIENTS. THIS IS THE SECOND OF TWO REPORTS. REFER TO 2026095-2022-00084 FOR THE FIRST REPORT. IT WAS REPORTED, DURING REMOVAL OF THE ON-Q SOAKER CATHETER THE [CATHETER] SNAPPED AND REMAINED INSIDE THE PATIENT; A SIZABLE CHUNK OF THE CATHETER (APPROXIMATELY 10 CM) REMAINED INSIDE THE PATIENT. THERE WAS NO REPORTED INJURY. ADDITIONAL INFORMATION RECEIVED 14-JUL-2022 REPORTED, THE PRODUCT HAD BEEN IN PLACE FOR FOUR (4) DAYS, NO INJURY WAS REPORTED. THE REPORTER NOTED THAT IT WAS UNCLEAR IF THE PATIENT WOULD REQUIRE SURGERY TO REMOVE THE CATHETER. ADDITIONAL INFORMATION RECEIVED 18-JUL-2022 REPORTED, THE PATIENT WAS OFFERED TO GO BACK TO THE THEATRE, FOLLOWING THE CT SCAN BUT THERE WERE CONCERNS OF THE RISKS OF GOING BACK TO THE THEATRE SO SOON AFTER FIRST SURGERY, AND THE REPORTEDLY THE PATIENT DID NOT FEEL UP TO IT. THE PATIENT WAS STARTED ON IV ANTIBIOTICS TO COVER AS THE FOREIGN BODY REMAINS.
Patient problems: Foreign Body In Patient
MAUDE report 15167818 ↗MalfunctionAug 4, 2022Material Integrity Problem; Material Integrity Problem
AVANOS MEDICAL INC. RECEIVED A SINGLE REPORT THAT REFERENCED TWO DIFFERENT INCIDENCES, WHICH WERE ASSOCIATED WITH SEPARATE UNITS, INVOLVING TWO DIFFERENT PATIENTS. THIS IS THE FIRST OF TWO REPORTS. REFER TO 2026095-2022-00085 FOR THE SECOND REPORT. IT WAS REPORTED, DURING REMOVAL OF THE ON-Q SOAKER CATHETER THE [CATHETER] SNAPPED AND REMAINED INSIDE THE PATIENT; A SIZABLE CHUNK OF THE CATHETER (APPROXIMATELY 10 CM) REMAINED INSIDE THE PATIENT. THERE WAS NO REPORTED INJURY. ADDITIONAL INFORMATION RECEIVED 14-JUL-2022 REPORTED, THE PRODUCT WAS IN PLACE FOR FOUR (4) DAYS, NO INJURY WAS REPORTED. THE REPORTER NOTED THAT IT WAS UNCLEAR IF THE PATIENT WOULD REQUIRE SURGERY TO REMOVE THE CATHETER. ADDITIONAL INFORMATION RECEIVED 18-JUL-2022 REPORTED, THE PATIENT WAS DUE TO HAVE AN X-RAY ONCE STABLE, IN ORDER TO VISUALIZE THE MISSING CATHETER, WHICH WAS RADIO OPAQUE.
Patient problems: Foreign Body In Patient
MAUDE report 15167676 ↗
Other CATHETER, CONDUCTION, ANESTHETIC devices
- ARROW IPN925037Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC7 recalls0 reports
- ARROW IPN924999Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC3 recalls0 reports
- ARROW IPN924964Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC2 recalls1 report
- ARROW IPN927743Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC2 recalls0 reports
- ARROW IPN922619Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC2 recalls0 reports
- ARROW IPN924975Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC2 recalls0 reports
- ARROW IPN925052Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC2 recalls0 reports
- ARROW IPN925020Teleflex Incorporated · CATHETER, CONDUCTION, ANESTHETIC2 recalls0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.